Miltefosine (Oral Treatment for Visceral Leishmaniasis)

Type: drug

Status: WHO Recommended

Developer: Asta Medica (originally for cancer), repurposed by WHO/DNDi

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026